BL22 immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BL22 immunotherapy, covering 2012-05-01 to 2012-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia [Phase 2]